연구성과로 돌아가기

2023 연구성과별 연구자 정보 (733 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Shin, Kyong Jin Shin, KJ 14 Inje Univ, Haeundae Paik Hosp, Dept Neurol, Busan, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Shin, Jin-Hong Shin, JH 15 Pusan Natl Univ, Dept Neurol, Yangsan Hosp, Yangsan, South Korea AAZ-8809-2020 Shin, Jin-Hong bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Shin, Jin-Hong Shin, JH 15 Pusan Natl Univ, Yangsan Hosp, Dept Neurol, Yangsan, South Korea AAZ-8809-2020 Shin, Jin-Hong
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Shin, Ha Young Shin, H 16 Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea 0000-0002-4408-8265 Shin, Ha Young bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Shin, Ha Young Shin, HY 16 Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Oh, Seong-il Oh, SI 17 Inje Univ, Busan Paik Hosp, Dept Neurol, Coll Med, Busan, South Korea A-8790-2019 Oh, Seong-il 0000-0002-8067-2135 Oh, Seong-il bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Oh, Seong-il Oh, SI 17 Inje Univ, Busan Paik Hosp, Coll Med, Dept Neurol, Busan, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Oh, Jeeyoung Oh, J 18 Konkuk Univ, Dept Neurol, Sch Med, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Oh, JeeYoung Oh, J 18 Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Yoon, Byeol-A Yoon, BA 19 Dong A Univ, Dept Neurol, Coll Med, Pusan, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Yoon, Byeol-A Yoon, BA 19 Dong A Univ, Coll Med, Dept Neurol, Busan, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Lee, Sanggon Lee, SG 20 Chung Ang Univ, Dept Neurol, Gwangmyeong Hosp, Gwangmyeong, South Korea JNR-4926-2023 lee, wj bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Lee, SangGon Lee, S 20 Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Lee, Jong-Mok Lee, JM 21 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Neurol, Daegu, South Korea KVY-9550-2024 Lee, Jong-Mok 0000-0002-2918-6166 Lee, Jong-Mok bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Lee, Jong-Mok Lee, JM 21 Kyungpook Natl Univ Hosp, Dept Neurol, Daegu, South Korea
페이지 이동: